Purchase Order 12405B19P0070
- Not listed
- Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V., was awarded a firm fixed-price purchase order on July 14, 2017, for 1,000 QuantiTect Probe polymerase chain reaction (PCR) kits with shipping. The contract, valued at $5,358.36, reflects intramall pricing and carries no set-aside designation, indicating open competition. The award was funded by a civilian federal agency with the Southeast Area designation, and the place of performance is Valencia, California. The contract is scheduled...
- Qiagen, LLC, a foreign-owned biotechnology manufacturer headquartered in Germantown, Maryland, was awarded a Blanket Purchase Agreement (BPA) call for in vitro products valued at $12,022.20 on October 19, 2017. This firm fixed price contract, issued by the Office of Logistics and Acquisition Operations, is scheduled for completion by April 30, 2018, with performance taking place in Germantown, Maryland. The award was made without a set-aside designation, indicating that Qiagen competed in the...
- Qiagen, LLC, a Germantown, Maryland-based manufacturer of molecular diagnostics and scientific equipment, was awarded an $20,805.12 firm fixed price blanket purchase agreement (BPA) call by a civilian federal agency's Office of Logistics and Acquisition Operations on August 24, 2017. The contract, classified as an in vitro substance procurement, was completed by April 30, 2018, with performance conducted in Germantown, Maryland. No set-aside designation was applied to this award, allowing the...
- On September 30, 2017, the Pacific West Area (a civilian federal agency) awarded a $3,798.97 firm fixed-price purchase order to Qiagen, LLC for QIAGEN ONESTEP RT-PCR Kit #210212 and QIAAMP Viral RNA Mini Kit #52906, with an ultimate completion date of October 31, 2017. The contract was awarded without set-aside designation, allowing Qiagen to compete in the open federal marketplace. The place of performance was Valencia, California. Qiagen, LLC is a subsidiary of Qiagen N.V., a Netherlands-based...
- Qiagen, LLC, a foreign-owned manufacturer of molecular diagnostics and scientific equipment headquartered in Germantown, Maryland, was awarded a Blanket Purchase Agreement (BPA) call for chemicals by a civilian federal agency on May 15, 2019. The contract carries a ceiling value of $18,901.08 under a firm fixed-price arrangement with an ultimate completion date of April 30, 2020. The work will be performed in Germantown, Maryland. This award was not issued under any set-aside designation,...
- Qiagen, LLC, a foreign-owned molecular diagnostics manufacturer headquartered in Germantown, Maryland, received a Blanket Purchase Agreement (BPA) call award on November 20, 2019, from the Office of Logistics and Acquisition Operations for chemicals. The contract, which operated under a firm fixed price structure with no set-aside designation, carried a ceiling value of $20,409.60 and an ultimate completion date of April 30, 2020. Performance was conducted at Qiagen's Germantown, Maryland...
- Qiagen, LLC, a foreign-owned molecular diagnostics and scientific equipment manufacturer headquartered in Germantown, Maryland, received a Blanket Purchase Agreement (BPA) call award valued at $10,010.32 from the Office of Logistics and Acquisition Operations on April 20, 2024. This firm fixed-price contract, which does not utilize a set-aside designation, is for chemicals and carries an ultimate completion date of April 30, 2025. The work will be performed in Germantown, Maryland. This award...
- On January 30, 2018, the Office of Logistics and Acquisition Operations awarded a Blanket Purchase Agreement (BPA) call valued at $4,258.44 to Qiagen, LLC, a foreign-owned manufacturer of molecular diagnostics and scientific equipment headquartered in Germantown, Maryland. This firm fixed price contract, which was not issued under a set-aside designation, has an ultimate completion date of April 30, 2018, with the place of performance in Germantown, Maryland. Qiagen, LLC operates as a subsidiary...
- Qiagen, LLC, a foreign-owned molecular diagnostics manufacturer headquartered in Germanwood, Maryland, was awarded a $3,169.44 firm fixed-price call against a Blanket Purchase Agreement (BPA) by a civilian federal agency on May 16, 2014. The contract, which is not designated with any set-aside provision, covers medical and surgical instruments, equipment, and supplies with a completion date of December 31, 2014. Performance is to be conducted in Valencia, California. This call represents a...
- Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V., received a purchase order award from the Plains Area civilian federal agency for RT2 kits valued at $5,263.30. The contract, awarded on January 25, 2018, with an ultimate completion date of January 31, 2018, utilized firm fixed-price pricing with no set-aside designation. Performance of this work will be executed in Valencia, California. As a leading provider of molecular diagnostics and scientific equipment, Qiagen regularly supplies...
Qiagen, LLC, a foreign-owned molecular diagnostics and scientific equipment manufacturer headquartered in Germantown, Maryland, received a $9,527.73 firm fixed-price purchase order from a civilian federal agency for 400 reaction units of QuantiTect RT PCR Kit. The award, issued on February 6, 2019, with an ultimate completion date of February 14, 2019, represents a modification to add funds matching the vendor's order total. The contract was awarded without a set-aside designation, reflecting Qiagen's competitive standing in the open federal marketplace. The place of performance is Germantown, Maryland. The QuantiTect RT PCR Kit is a reverse transcription polymerase chain reaction reagent used for nucleic acid analysis in research and diagnostic applications. This procurement aligns with Qiagen's extensive federal contract portfolio, which includes supplying molecular diagnostics products, reagents, and specialized laboratory equipment to agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Veterans Affairs. The company maintains several significant indefinite delivery vehicles across federal agencies, including blanket purchase agreements with the Defense Health Agency and the National Institute of Environmental Health Sciences, positioning it as a reliable supplier of critical molecular biology consumables to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $70 | 2/7/19 | |
| Not listed | Not listed | $9.5k | 2/6/19 |